Joe Hayden Ray Brown Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Edwardsville Rd, Troy, IL 62294 Phone: 618-667-4267 |
Mrs. Patricia Ellen Miller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 E Market, Troy, IL 62294 Phone: 618-667-6726 Fax: 618-667-6972 |
Jessica Beth Hemker, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Edwardsville Rd, Troy, IL 62294 Phone: 618-667-4267 Fax: 618-667-4596 |
Alyse D Battles, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Edwardsville Rd, Troy, IL 62294 Phone: 618-667-4267 |
Megan Elizabeth Stafford, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Edwardsville Rd, Troy, IL 62294 Phone: 618-667-4267 |
Karen Stephens, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 83 W Lake Dr, Troy, IL 62294 Phone: 618-667-7665 |
Leanne M Mcdonald Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Edwardsville Rd, Troy, IL 62294 Phone: 618-667-4267 Fax: 618-667-4596 |
Dr. Larrah Lenn Duckworth, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 Edwardsville Rd, Troy, IL 62294 Phone: 618-667-4267 Fax: 618-667-4596 |
News Archive
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for its "DNA expression vectors and methods of use. Issued on September 14, 2010, the patent claims cover novel vectors and novel HIV vaccine inserts.
Three years ago, on a Friday afternoon, I received a frantic phone call from my mother. My active and healthy father was in the hospital with a suspected stroke. I immediately started driving to New Jersey, where they lived. I knew I had to be there to ensure that my dad would be safe. He had been taken to one of the most dangerous places in the world: a hospital. The story of my dad's three day stay in a major American teaching hospital is remarkably unremarkable (Ashish Jha, 4/5).
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
Researchers from the School of Immunology & Microbial Sciences have engineered a novel way of delivering gene therapy that they hope will mean scientists and doctors can target areas of the brain that were previously difficult to reach.
› Verified 9 days ago